Skip to main content

Day: September 13, 2022

Manhattan Associates Helps Floor & Decor Unify Its Supply Chain

Leading specialty retailer upgrades to Manhattan’s cloud-native suite of supply chain solutions ATLANTA, Sept. 13, 2022 (GLOBE NEWSWIRE) — Manhattan Associates Inc. (NASDAQ: MANH) today announced that Floor & Decor, a leading specialty retailer of hard surface flooring, has chosen to upgrade its existing Manhattan solutions to Manhattan Active® Supply Chain, a landmark advancement in supply chain efficiency and optimization. This decision provides Floor & Decor with enterprise-wide supply chain unification via the most modern cloud-native software infrastructure available.  With over 174 warehouse store locations in the US, Floor & Decor is a successful and rapidly growing specialty retailer of hard surface flooring and related accessories. With its continued growth, Floor & Decor recently decided to build on...

Continue reading

SharpLink Gaming Announces Results of 2022 Annual General Meeting of Shareholders

MINNEAPOLIS, Sept. 13, 2022 (GLOBE NEWSWIRE) — SharpLink Gaming Ltd. (Nasdaq: SBET) (“SharpLink” or the “Company”), a pioneer of targeted, data-driven user engagement and conversion solutions for the U.S. sports betting and iGaming industries, today announced the following resolutions were adopted at the 2022 Annual General Meeting of Shareholders that was held Thursday, September 8, 2022, in Minneapolis, Minnesota.To reelect Joe Housman, Rob Phythian, Chris Nicholas, Paul Abdo and Tom Doering as members of the board of directors for a term expiring at our 2023 Annual General Meeting of Shareholders and when their successors are elected and qualified; To ratify and approve the appointment of RSM US LLP, registered public accountants, as our independent registered public accountants for the year ending December 31, 2022 and to...

Continue reading

Noble Corporation plc has announced the final results of the recommended voluntary public share exchange offer and has requested Maersk Drilling to seek a delisting of the shares from Nasdaq Copenhagen

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. Reference is made to company announcement no. 17/2022 regarding the preliminary results of the recommended voluntary public share exchange offer (the “Exchange Offer”) by Noble Corporation plc (“Topco”) to the shareholders of The Drilling Company of 1972 A/S (“Maersk Drilling”). Reference is also made to the Topco announcement attached hereto. Result of the Exchange OfferPursuant to the terms of the Offer Document, the Exchange Offer expired on 8 September 2022 at 23:59 (CEST). In accordance with section 21(3) of the Danish Executive Order no. 636 of 15 May 2020 on takeover bids (the “Danish Takeover...

Continue reading

Cellectar Announces Publication of Data from Its Expansion Cohort of the Phase II CLOVER-1 Study Iopofosine I-131 in Relapsed/Refractory Multiple Myeloma in Nature’s Blood Cancer Journal

Initial data show ORR of 50% in Quad-Class Refractory Multiple Myeloma Patients Who Have Failed anti-BCMA Immunotherapy with Median of Nine Lines of Prior Therapy FLORHAM PARK, N.J., Sept. 13, 2022 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted treatments for cancer, today announced the publication of a paper highlighting data from an expansion cohort of the ongoing Phase 2 CLOVER-1 study of iopofosine I-131 (“iopofosine”) in relapsed/refractory B-cell malignancies in the September issue of Blood Cancer Journal, a peer-reviewed Nature journal. The paper, entitled “Iopofosine I-131 treatment in late-line patients with relapsed/refractory multiple myeloma post anti-BCMA immunotherapy,” showed initial results...

Continue reading

Nuvectis Pharma Announces Positive Data for NXP800 in a Preclinical Model of ARID1a-Mutated Gastric Carcinoma

ARID1a- mutated gastric carcinoma model (SNU-1) Tumor volumes over timeFORT LEE, N.J., Sept. 13, 2022 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (“Nuvectis”, “Company”), a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced positive data for NXP800 in a preclinical xenograft model of ARID1a-mutated gastric carcinoma. “Following the strong preclinical proof of concept in ARID1a-mutated ovarian carcinoma models, we are very pleased with this new preclinical data for NXP800 in ARID1a-mutated gastric cancer, potentially expanding the development opportunity for NXP800 to an additional therapeutic area with a clear unmet need,” said Ron Bentsur, Chairman and Chief Executive Officer of Nuvectis. Mr. Bentsur continued,...

Continue reading

Skkynet Announces Q3 2022 Financial Results

Continuing growth drives positive outlook for future with 12% YoY revenue increase Mississauga, Ontario, Sept. 13, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Skkynet Cloud Systems, Inc. (“Skkynet” or “the Company”) (OTCQB: SKKY) is pleased to announce its quarter-end operating and financial results for the period ended July 31, 2022.  The Company reported a record third quarter revenue of $530,075 compared to $497,375 for the same period in 2021, marking a 7% growth in sales.  Net income from operations for Q3 was $18,366 compared to a net loss of $15,490 for the same period in 2021.  The Company reported a record nine-month revenue total of $1,547,347 compared to $1,383,414 for the same period in 2021, a 12% growth in sales. “Skkynet’s Q3 2022 results have met our expectations for continued momentum and revenue growth for...

Continue reading

MILLER/HOWARD HIGH INCOME EQUITY FUND ANNOUNCES 6.25% DISTRIBUTION INCREASE

Kingston, NY, Sept. 13, 2022 (GLOBE NEWSWIRE) — The Board of Trustees of the Miller/Howard High Income Equity Fund (NYSE: HIE) (the “Fund”) declares cash distributions of $0.051 per share for each of October, November, and December 2022. This is a 6.25% increase from the previous monthly distribution of $0.048 per share. The change in distribution takes into account the current market environment, Miller/Howard Investments Inc.’s (the investment adviser to the Fund [the “Adviser” or “Miller/Howard”]) outlook regarding the dividends and distributions of the companies in the Fund’s universe, and the projected proceeds from other investment activities. “In recent quarters, dividend increases have been a common theme across the universe of higher-yielding equities,” said Michael Roomberg, CFA, Portfolio Manager at Miller/Howard. “Consistent...

Continue reading

Luciana de Oliveira Cezar Coelho and Fernando Prezzotto Join Verde’s Board of Directors

BELO HORIZONTE, Brazil, Sept. 13, 2022 (GLOBE NEWSWIRE) — Verde AgriTech Ltd (TSX: “NPK”) (“OTCMKTS: “VNPKF“) (the “Company”) is pleased to announce the appointment of Luciana de Oliveira Cezar Coelho and Fernando Prezzotto (the “Directors”) to its Board of Directors (the “Board”). “As we start a carefully planned renewal of the Board, we welcome Mrs. Oliveira Cezar Coelho and Mr. Prezzotto, whose agricultural sector experience and deep understanding of Brazil will further strengthen Verde’s Board”, declared Verde’s Director, Renato Gomes. “As someone with a career devoted to Brazilian agriculture and relevant technology, I am pleased to join Verde AgriTech because its mission of supplying a superior local source of potash and micronutrients to farmers is something I strongly believe in and know that I can...

Continue reading

DNO Extraordinary General Meeting Approves Share Capital Increase

Oslo, 13 September 2022 – DNO ASA, the Norwegian oil and gas operator, today held an Extraordinary General Meeting in Oslo at which the proposal to increase the Company’s share capital received near unanimous support of over 99 percent of the votes cast. The Company will issue 78,943,763 new shares for subscription by RAK Petroleum plc, subject to the fulfilment of certain conditions set out in the transaction agreement entered between DNO and RAK Petroleum by which the Company will acquire assets in West Africa, as referenced in a 22 August 2022 stock exchange announcement. The total shares outstanding following the completion of the transaction will be 1,054,376,509‬, each with a nominal value of NOK 0.25. The minutes from the Extraordinary General Meeting are attached. – For further information, please contact:Media: media@dno.noInvestors:...

Continue reading

Neuronetics, Inc. Announces Grand Opening of NeuroStar® University with Ribbon-Cutting Ceremony

The state-of-the-art training center is the first of its kind to further best practices with transformative NeuroStar Advanced Therapy for Mental HealthNeuroStar University in Charlotte, North Carolina The first NeuroStar University Class in Charlotte, North CarolinaMALVERN, Pa., Sept. 13, 2022 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced the grand opening of NeuroStar® University (NSU) in Charlotte, North Carolina, the transcranial magnetic stimulation (TMS) industry’s first of its kind training facility. A ribbon-cutting event will take place on Tuesday, September 13th to celebrate the state-of-the-art facility. “We’re...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.